全文获取类型
收费全文 | 1920253篇 |
免费 | 136143篇 |
国内免费 | 7119篇 |
专业分类
耳鼻咽喉 | 24588篇 |
儿科学 | 62720篇 |
妇产科学 | 51552篇 |
基础医学 | 278786篇 |
口腔科学 | 51348篇 |
临床医学 | 172178篇 |
内科学 | 380113篇 |
皮肤病学 | 45116篇 |
神经病学 | 147003篇 |
特种医学 | 79583篇 |
外国民族医学 | 417篇 |
外科学 | 295531篇 |
综合类 | 38689篇 |
现状与发展 | 4篇 |
一般理论 | 510篇 |
预防医学 | 151568篇 |
眼科学 | 41734篇 |
药学 | 138060篇 |
8篇 | |
中国医学 | 3263篇 |
肿瘤学 | 100744篇 |
出版年
2018年 | 20988篇 |
2017年 | 17257篇 |
2016年 | 19365篇 |
2015年 | 22736篇 |
2014年 | 29194篇 |
2013年 | 40982篇 |
2012年 | 57224篇 |
2011年 | 56793篇 |
2010年 | 34151篇 |
2009年 | 34181篇 |
2008年 | 50629篇 |
2007年 | 55108篇 |
2006年 | 55858篇 |
2005年 | 61467篇 |
2004年 | 61056篇 |
2003年 | 55472篇 |
2002年 | 48876篇 |
2001年 | 85961篇 |
2000年 | 86234篇 |
1999年 | 75081篇 |
1998年 | 21234篇 |
1997年 | 18647篇 |
1996年 | 19665篇 |
1995年 | 19628篇 |
1994年 | 18186篇 |
1993年 | 17145篇 |
1992年 | 63168篇 |
1991年 | 63280篇 |
1990年 | 61622篇 |
1989年 | 59213篇 |
1988年 | 54778篇 |
1987年 | 53967篇 |
1986年 | 50734篇 |
1985年 | 48596篇 |
1984年 | 36530篇 |
1983年 | 30758篇 |
1982年 | 18010篇 |
1981年 | 16127篇 |
1979年 | 33769篇 |
1978年 | 24058篇 |
1977年 | 19976篇 |
1976年 | 18883篇 |
1975年 | 21068篇 |
1974年 | 24662篇 |
1973年 | 23460篇 |
1972年 | 21827篇 |
1971年 | 20420篇 |
1970年 | 18934篇 |
1969年 | 17724篇 |
1968年 | 16568篇 |
排序方式: 共有10000条查询结果,搜索用时 9 毫秒
31.
Lalia Y. Ibrahim Krank P. DiFilippo Geremy E. Steed Manuel D. Cerqueira 《Journal of nuclear cardiology》2006,13(6):855-866
Conclusion Several quality-control measures take place before (patient and camera preparation) and during SPECT acquisition to achieve
high-quality images. Not uncommonly, technologists and physicians are left with suboptimal images that have to be addressed
to reach the “right answer” for patient diagnosis and hence management. In many cases patients may be reimaged, especially
if the problem is detected early, but in other cases either the patient has left the nuclear laboratory or there is an inevitable
problem that, even with reimaging, will not be resolved. In these situations the technologist and physician have to seek the
available techniques to obtain the best images possible. These resources are discussed in this issue as an aid in quality
control to obtain the best possible images. 相似文献
32.
Jaros?aw Felu? Wojciech Rad?o Bart?omiej Kowalczyk 《Chirurgia narzadów ruchu i ortopedia polska》2006,71(2):107-112
Nine wrists in eight patients were treated surgically between 1988 and 2003 for symptomatic Madelung's deformity. The pain of involved wrist followed by forearm deformation fulfilled criteria for surgery. Closing wedge osteotomy of the distal radius were carried out eight times accompanied by shortening of the ulna (four patients), excision of the distal ulna (one patient), and no ulnar surgery (three patients). Pain relieved after surgery. The follow up period ranged from 1 to 9.5 years. No pour results were stated in subjective patient's estimation during final check up. Wrist appearance were stated to be satisfactory. Limitation of the range of motion concerning supination and pronation of the forearm were stated invariably. X-ray retrospective assessment of the inclination angle, lunate coverage and presence of arthritic changes were conducted. Time and method of surgical treatment for Madelung's deformity should be considered individually. 相似文献
33.
34.
D B Irving J L Cook H B Menz 《Journal of Science and Medicine in Sport》2006,9(1-2):11-22; discussion 23-4
35.
36.
37.
38.
Steven V Koenen Anjoke J M Huisjes Jules Dings Yolanda van der Graaf Gerard H A Visser Hein W Bruinse 《The journal of maternal-fetal & neonatal medicine》2006,19(2):93-99
OBJECTIVE: To determine if there is a diurnal pattern in the clinical symptoms of HELLP (Hemolysis, Elevated Liver enzymes, Low Platelets) syndrome. STUDY DESIGN: A retrospective study was performed in 134 pregnancies complicated by HELLP syndrome. The medical records were reviewed to describe each HELLP episode. Time of day was divided into three periods, day, evening, and night. The following parameters were categorized according to the time of day: onset of symptoms, consultation by the doctor, initial blood sampling, diagnosis and decrease of symptoms. Biochemical parameters at clinical presentation and consecutive changes within 24 h were recorded. RESULTS: In 65 pregnancies 77 HELLP episodes were well documented. Times of onset of symptoms and consultation by the doctor were significantly higher during the evening and night (p < 0.001), whereas times of diagnosis and decrease of symptoms occurred significantly more during the day (p < 0.001). In only 49.3% of the cases were diagnostic laboratory criteria met at clinical presentation. This was mainly due to platelet values in excess of 100 x 10(9)/l. Several hours later (median 8 h, range 2-23) the decrease in platelets occurred. CONCLUSIONS: A diurnal pattern exists in the clinical symptoms of HELLP syndrome that is characterized by an exacerbation during the night and recovery during the day. There is a considerable delay between the onset of symptoms and the fulfillment of diagnostic laboratory criteria. 相似文献
39.
A-C Koschker M Fassnacht S Hahner D Weismann B Allolio 《Experimental and clinical endocrinology & diabetes》2006,114(2):45-51
BACKGROUND: Adrenocortical carcinoma (ACC) is a rare and highly malignant tumour with a poor prognosis. Patients present with signs of steroid hormone excess (e.g., Cushing's syndrome) or symptoms due to an abdominal mass. DIAGNOSIS: In case of an adrenal mass, hormonal workup before surgery is required for differential diagnosis, perioperative management, and for follow-up. The imaging of choice is CT or MRI with MRI being of additional use when invasion of big vessels is suspected. Apart from that, the use of 18-FDG-PET is becoming increasingly established. TREATMENT: Surgical resection is the therapeutic option of choice in stages 1 - 3. In stage 4, the adrenolytic compound mitotane is part of the first-line treatment, but often needs to be combined with cytotoxic chemotherapy. Most patients will eventually have a recurrence, so adjuvant treatment (mitotane/tumour bed radiation) has to be considered in high risk patients, even if randomized controlled trials on adjuvant treatment are still lacking. STRUCTURAL PROGRESS: Several national and European structures have recently been established in order to increase our knowledge of ACC, improve therapeutic options and diagnostic procedures, and promote research. GANIMED, as a Germany-wide network of experts on adrenal diseases, has been founded allowing for improved gathering of data and joint studies. ENSAT (European Network for the Study of Adrenal Tumours) has been brought to life, aiming at European standards for therapy, diagnosis and tumour banking. Since 2003, patients can be enrolled in the German ACC Registry. France and Italy have also developed a central registry to collect nationwide data from patients with ACC. For the first time, patients with metastatic/unresectable ACC can participate in a prospective controlled randomized trial comparing two different cytotoxic chemotherapy regimes (FIRM-ACT). 相似文献
40.
B Dederichs M Dietlein B Jenniches-Kloth M Schmidt P Theissen D Moka H Schicha 《Experimental and clinical endocrinology & diabetes》2006,114(7):366-370
BACKGROUND: Radioiodine therapy (RIT) combined with glucocorticoids is an effective therapy for Graves' disease, but it is debatable whether glucocorticoids should be applied in patients without Graves' ophthalmopathy (GO). METHODS: The effect of 0.4 - 0.5 mg prednisone every second day over a period of 5 weeks after RIT was monitored over a follow-up period of at least 12 months after RIT. A questionnaire was sent to 186 consecutive patients without GO concerning eye symptoms after RIT. 148 patients (80 %) answered. If eye symptoms had occurred after RIT, additional clinical examination was carried out at our outpatient clinic. The primary endpoint was the absence or onset of GO within the first year after RIT. RESULTS: Within 12 months after RIT the examination confirmed GO in 5 out of 148 patients (3.4 %). In all cases the symptoms were transient. No adverse reaction to the use of prednisone after RIT was noted. CONCLUSIONS: The risk of new GO in the first year after RIT was low and the clinical course of GO was mild when RIT was combined with a low-dose glucocorticoid regimen. Preventive administration of glucocorticoids can therefore be recommended in patients with Graves' disease even without evident GO. 相似文献